Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
24.92
-0.62 (-2.43%)
Jun 26, 2026, 3:26 PM EDT - Market open
Cue Biopharma Revenue
Cue Biopharma had revenue of $5.69M in the quarter ending March 31, 2026, with 1,250.59% growth. This brings the company's revenue in the last twelve months to $32.73M, up 309.60% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth.
Revenue (ttm)
$32.73M
Revenue Growth
+309.60%
P/S Ratio
3.16
Revenue / Employee
$1,128,655
Employees
29
Market Cap
100.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.47M | 18.18M | 195.75% |
| Dec 31, 2024 | 9.29M | 3.80M | 69.16% |
| Dec 31, 2023 | 5.49M | 4.25M | 340.96% |
| Dec 31, 2022 | 1.25M | -13.70M | -91.67% |
| Dec 31, 2021 | 14.94M | 11.79M | 373.68% |
| Dec 31, 2020 | 3.15M | -304.00K | -8.79% |
| Dec 31, 2019 | 3.46M | 2.32M | 202.67% |
| Dec 31, 2018 | 1.14M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Black Diamond Therapeutics | 70.00M |
| Fortress Biotech | 66.16M |
| Verrica Pharmaceuticals | 37.16M |
| Pelthos Therapeutics | 27.70M |
| Cibus | 4.29M |
| Alps Group | 3.74M |
CUE News
- 8 days ago - Cue Biopharma Registration statement: Registration filing - Filings
- 23 days ago - Cue Biopharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Cue Biopharma Slides: FY 2026 - Filings
- 23 days ago - Cue Biopharma Registration statement: Registration filing - Filings
- 23 days ago - Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution - GlobeNewsWire
- 25 days ago - Cue Biopharma Transcript: EGM 2026 - Transcripts
- 5 weeks ago - Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Cue Biopharma Proxy statement: Proxy filing - Filings